What was Lophos Holdings, Inc.’s price range in the past 12 months?
Lophos Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.01 in the past 12 months.
What is Lophos Holdings, Inc.’s market cap?
Lophos Holdings, Inc.’s market cap is C$879.85K.
When is Lophos Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lophos Holdings, Inc.’s earnings last quarter?
Lophos Holdings, Inc. released its earnings results on Feb 29, 2024. The company reported -C$0.006 earnings per share for the quarter.
Is Lophos Holdings, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Lophos Holdings, Inc. pay dividends?
Lophos Holdings, Inc. does not currently pay dividends.
What is Lophos Holdings, Inc.’s EPS estimate?
Lophos Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lophos Holdings, Inc. have?
Lophos Holdings, Inc. has 29,328,224 shares outstanding.
What happened to Lophos Holdings, Inc.’s price movement after its last earnings report?
Lophos Holdings, Inc. reported an EPS of -C$0.006 in its last earnings report. Following the earnings report the stock price went down -33.333%.
Which hedge fund is a major shareholder of Lophos Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:MESC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lophos Holdings, Inc.
Lophos Holdings Inc. se rapporte à la culture et à la recherche de Lophophora williamsii (« cactus peyotl »). De plus, à long terme, la Société est engagée dans la recherche et le développement de composés dérivés du cactus peyotl. La filiale en propriété exclusive de la société, Lophos Pharmaceuticals Corp., est une société de biosciences spécialisée dans la culture, la recherche et la vente de cactus peyotl. Elle est également autorisée à posséder, produire, vendre/fournir, envoyer, transporter et livrer les substances contrôlées couvertes par sa licence de revendeur de substances contrôlées (CSDL), à savoir la mescaline, la psilocine et la psilocybine.
Sector
General
Industry
Biotechnology
CEO
Jacqueline Claire Lupo
Employees
1
Website
lophos.com/contact-us/
Address
620.0,1111 Melville Street, Vancouver, BC, V6E 3V6, CA